For over 30 years in practice, I have sat across from countless women experiencing irregular periods, unexplained weight gain, severe acne, and heartbreaking fertility struggles. For decades, I had to give them a diagnosis that I knew was fundamentally flawed: Polycystic Ovary Syndrome (PCOS).
In May 2026, the medical community finally corrected this historic misnomer. Following a 14-year global consensus process published in The Lancet, PCOS has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS).
If you have been diagnosed with PCOS in the past, your diagnosis has not changed. But how we talk about it, understand it, and treat it just took a massive leap forward. Here is why the old name had to go, and why PMOS better reflects the reality of what your body is actually experiencing.
The Problem with "Polycystic"
The biggest issue with the name PCOS was the word "polycystic." It pointed both doctors and patients directly toward the ovaries, implying that abnormal cysts were the defining feature of the disease.
Here is the truth: they are not actually cysts.
What appear as "cysts" on a pelvic ultrasound are actually arrested follicles—partly developed eggs that stopped maturing because the hormonal environment was not quite right for ovulation. Furthermore, they do not occur in greater numbers than in many women without the condition, and not every woman with the syndrome even has them.
For years, this anatomical focus caused devastating diagnostic delays. A woman would come to my clinic with classic symptoms—hair loss, insulin resistance, disrupted cycles—but if her ultrasound looked clear, she was often dismissed and told she didn't have PCOS. The real underlying problems went unaddressed because the medical field was too focused on a single organ.
Breaking Down PMOS: A Whole-Body Approach
The new name, PMOS, correctly identifies the condition as a systemic, whole-body issue. Let's break down what the new terminology means for your health:
Polyendocrine: This acknowledges that the condition involves multiple interacting hormonal systems, not just the ovaries. It encompasses elevated androgens (male hormones like testosterone), disrupted signals from the brain, and systemic imbalances that drive physical symptoms like excessive facial hair growth and cystic acne.
Metabolic: This is the most crucial addition. Up to 70% of women with this condition have underlying insulin resistance. By explicitly including "metabolic" in the name, it forces the medical field to acknowledge how the body processes insulin, glucose, and fat. It means we must proactively screen for and manage the elevated risks of type 2 diabetes, fatty liver disease, and cardiovascular issues, rather than treating them as unrelated side effects.
Ovarian: The ovaries remain a central site of dysfunction, particularly regarding egg development, cycle regularity, and fertility. Keeping this word ensures that reproductive health and family planning remain a core pillar of care.
Syndrome: A reminder that this is a collection of features and risks that present differently in every single woman. No two PMOS patients look exactly alike.
What This Means for Your Care
If you were diagnosed with PCOS last year, you have PMOS today. You do not need a new diagnosis or new testing just because the name changed. Your current treatment plan—whether it involves ovulation induction, lifestyle modifications, or insulin-sensitizing medications—remains valid.
However, the shift to PMOS brings a critical change in medical mindset. For too long, women with this condition were simply told to "lose weight" or were handed birth control pills and told to come back when they wanted to get pregnant. The PMOS framework demands that clinicians look at your metabolic health just as closely as your menstrual chart.
It validates that your exhaustion, your intense sugar cravings, and your difficulty losing weight are biologically driven by metabolic dysfunction, not a lack of willpower. As a physician who has watched the clinical understanding of this condition evolve over three decades, I can confidently say this is more than just a rebranding. It is a long-overdue validation of what millions of women have been experiencing all along.